Trial · NCT01657019
Results by group39
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 39
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percentage of Participants With Treatment-Emergent Adverse Events (TEAEs) as a Measure of Safety | All Participants | Any TEAE | 84.5 | percentage of participants | |
| Percentage of Participants With Treatment-Emergent Adverse Events (TEAEs) as a Measure of Safety | All Participants | Serious TEAEs | 2.8 | percentage of participants | |
| Number of Participants With a Positive Response on The Columbia Suicide Severity Rating Scale (C-SSRS) | All Participants | Suicidal behavior | 0 | participants | |
| Number of Participants With a Positive Response on The Columbia Suicide Severity Rating Scale (C-SSRS) | All Participants | Active suicidal ideation | 2 | participants | |
| Number of Participants With a Positive Response on The Columbia Suicide Severity Rating Scale (C-SSRS) | All Participants | Non-suicidal self-injurious behavior | 3 | participants | |
| Percentage of Participants With an Improved Response on The Clinical Global Impressions of Improvement (CGI-I) Scale | All Participants | Visit 1 (Week 1), n=589 | 53.7 | 95% Confidence Interval 49.6 to 57.7 | percentage of participants |
| Percentage of Participants With an Improved Response on The Clinical Global Impressions of Improvement (CGI-I) Scale | All Participants | Visit 4 (Week 4), n=572 | 88.5 | 95% Confidence Interval 85.8 to 91.1 | percentage of participants |
| Percentage of Participants With an Improved Response on The Clinical Global Impressions of Improvement (CGI-I) Scale | All Participants | Visit 9 (Week 24), n=466 | 92.7 | 95% Confidence Interval 90.3 to 95.1 | percentage of participants |
| Percentage of Participants With an Improved Response on The Clinical Global Impressions of Improvement (CGI-I) Scale | All Participants | Visit 16 (Week 52), n=369 | 95.4 | 95% Confidence Interval 93.2 to 97.5 | percentage of participants |
| Percentage of Participants With an Improved Response on The Clinical Global Impressions of Improvement (CGI-I) Scale | All Participants | End of Treatment, n=597 | 89.9 | 95% Confidence Interval 87.5 to 92.3 | percentage of participants |
| Change From Baseline in The Global Score for The Eating Disorder Examination Questionnaire (EDE-Q) | All Participants | Visit 4 (Week 4), n=483 | -1.66 | Standard Deviation 1.156 | units on a scale |
| Change From Baseline in The Global Score for The Eating Disorder Examination Questionnaire (EDE-Q) | All Participants | Visit 9 (Week 24), n=391 | -1.95 | Standard Deviation 1.271 | units on a scale |
| Change From Baseline in The Global Score for The Eating Disorder Examination Questionnaire (EDE-Q) | All Participants | Visit 16 (Week 52), n=314 | -1.95 | Standard Deviation 1.261 | units on a scale |
| Change From Baseline in The Global Score for The Eating Disorder Examination Questionnaire (EDE-Q) | All Participants | End of Treatment, n=503 | -1.90 | Standard Deviation 1.284 | units on a scale |
| Percentage of Participants With a Response to The EuroQoL Group 5 Dimension 5-Level Self-Report Questionnaire (EQ-5D-5L) For Mobility | All Participants | I have no problems in walking about | 91.2 | percentage of participants at ET | |
| Percentage of Participants With a Response to The EuroQoL Group 5 Dimension 5-Level Self-Report Questionnaire (EQ-5D-5L) For Mobility | All Participants | I have slight problems in walking about | 6.8 | percentage of participants at ET | |
| Percentage of Participants With a Response to The EuroQoL Group 5 Dimension 5-Level Self-Report Questionnaire (EQ-5D-5L) For Mobility | All Participants | I have moderate problems in walking about | 1.4 | percentage of participants at ET | |
| Percentage of Participants With a Response to The EuroQoL Group 5 Dimension 5-Level Self-Report Questionnaire (EQ-5D-5L) For Mobility | All Participants | I have severe problems in walking about | 0.4 | percentage of participants at ET | |
| Percentage of Participants With a Response to The EuroQoL Group 5 Dimension 5-Level Self-Report Questionnaire (EQ-5D-5L) For Mobility | All Participants | I am unable to walk about | 0.2 | percentage of participants at ET | |
| Percentage of Participants With a Response to The EuroQoL Group 5 Dimension 5-Level Self-Report Questionnaire (EQ-5D-5L) For Self Care | All Participants | I have no problems washing or dressing myself | 97.1 | percentage of participants at ET |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01657019/results